Page 22 - Healthcare

Cipla promoters sell 2.53% stake worth Rs 2,637 cr to fund philanthropy

ICICI Prudential MF, Aditya Birla Sun Life MF among top buyers

Need more doctors, hospital beds to achieve healthcare vision 2047: Report

There is a need to increase the number of qualified doctors to more than 50 lakh and also add 30 lakh more hospital beds in the country in order to achieve India's healthcare vision 2047, according to a report. The increase in the number of doctors and beds in hospitals would help India get closer to the average of developed countries, as per a FICCI-EY Report titled 'Decoding India's Healthcare Landscape'. India has witnessed a significant increase in the number of medical colleges and MBBS seats, addressing the growing demand for healthcare professionals, it said. The number of registered allopathic doctors witnessed substantial growth, rising from 6,60,801 in 2005 to 13,08,009 such doctors in 2022, the report said. Similarly, the bed capacity in government hospitals across India has consistently grown from 4.7 lakh beds in 2005 to 8.5 lakh beds in 2021. The report also highlighted the importance of having 100 per cent health insurance coverage for the country's population. It

Mutual funds embrace healthcare, finance stocks as smallcaps bounce back

Smallcap funds raked in net inflows of Rs 2,209 crore in April amid a sharp rally in smallcap shares

Zydus Wellness Q4 profit up 3.4%, driven by strong brand performance

For the full year of FY24, the company posted a 14 per cent Y-o-Y decline in PAT and the revenue grew by 3.2 per cent reaching Rs 266.9 crore and Rs 2,327.8 crore respectively

Manipal Hospitals rebrands AMRI units eight months after acquisition

Manipal Hospitals, which acquired an 84 per cent stake in AMRI Hospitals in September 2023 for around Rs 2,300 crore, announced brand integration on Tuesday

Indian senior living market has potential to touch $12 bn by 2030: Report

Rise in median age and ageing population to fuel increase in demand for senior housing

Not producing, distributing Covishield since December 2021: Serum Institute

AstraZeneca Covid vaccine row: As of April 30, 2024, over 1.7 billion doses of the Covishield vaccine has been administered in India

Legacy firms outperform modern, got 75% of PE-VC investments in 2023

75% of PE-VC investments were directed towards conventional sectors such as healthcare, retail, energy, advanced manufacturing

Wockhardt Hospitals launches early recovery program for liver transplant

The hospital group also claims that the ERP program improves the survival rate of the patients by approximately 2-3 per cent while enhancing patient outcomes through advanced techniques

P&G Health Q3 results: PAT dips 21% to Rs 46 cr, revenue at Rs 252 cr

Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024. The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago. Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing. "The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said. "However, we have seen sales recover in the months of March and April," he added.

Breathe easy! Philips says its sleep apnea devices safe for use in India

The company reached a $1.1 billion settlement for CPAP machine lawsuits in US

U-WIN may allow mothers to track and report vaccine side-effects on babies

Similar to the CoWIN portal for covid-19, the government's U-WIN platform registers and tracks routine vaccination and immunisation

Astrazeneca row: Only 7 in a million at risk of TTS, says ex-ICMR scientist

Former ICMR scientist Raman Gangakhedkar said the risk is highest after the initial dose, eventually decreasing with subsequent doses

AstraZeneca vaccine: From its origin to side effects, all you need to know

Manufactured first in 2021, the AstraZeneca vaccine, known in India as Covishield, has been facing scrutiny over the years, with many countries banning it back in 2021 itself

Healthcare industry announces support for talks on standardising rates

Many industry bodies too had become party to the case, urging the apex court to listen to their grievances as well

AstraZeneca admits its Covishield vaccine may lead to rare side effect

AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause rare side effects, marking an about-turn that may open the door for a multi-million pound legal payout

Pakistani teen receives life-saving heart transplant in Chennai hospital

The hospital and Chennai-based NGO helped Pakistani family settle bill of more than Rs 35 lakh for the transplant

CGHS ID mandatory linking with ABHA deadline extension: Details here

Linking deadline will from June 30 extended to 120 days, from 30 days now

Healthy occupancies, ARPOB to drive double-digit growth for pvt hospitals

The expected revenue growth in FY25 comes on the back of an estimated 14% growth in the last financial year

Former Pakistan PM Nawaz Sharif to 'undergo health checkup' in China

Three-time former Pakistan premier Nawaz Sharif will embark on Monday on a five-day personal visit to China, where he will undergo a medical checkup, according to a media report. This will be 74-year-old Sharif's first international visit after he returned to Pakistan in October last year following a four-year self-imposed exile in the UK. The Pakistan Muslim League-Nawaz (PML-N) supremo will be accompanied by Foreign Minister Ishaq Dar on his "personal visit", Geo News reported on Monday. Sharif's visit is personal and during the trip, he will undergo a medical checkup, the report said, quoting party sources. The former prime minister would also hold meetings related to the development works of the Punjab province and will also meet the owners of Chinese companies, sources said. The PML-N leader was allowed by a high court in November 2019 to go abroad on health grounds after his medical reports revealed that he needed urgent treatment. He returned to Pakistan from London in Oct